MITF and BRN2 contribute to metastatic growth after dissemination of melanoma
Jacinta L. Simmons(QIMR Berghofer Medical Research Institute), Glen M. Boyle(Queensland University of Technology)
Cited by 63
Related Papers
Intra-Lesional Injection of the Novel PKC Activator EBC-46 Rapidly Ablates Tumors in Mouse Models
|PLoS ONE|2014|86
BRN2 expression increases anoikis resistance in melanoma
|Oncogenesis|2020|36
BRN2 and MITF together impact AXL expression in melanoma
|bioRxiv (Cold Spring Harbor Laboratory)|2020|0